Saratoga Research & Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$94.1M Buy
1,203,285
+27,714
+2% +$2.24M 5.15% 8
2026
Q1
$102M Buy
1,175,571
+20,425
+2% +$1.96M 5.78% 7
2025
Q4
$111M Sell
1,155,146
-15,796
-1% -$1.53M 5.82% 6
2025
Q3
$112M Sell
1,170,942
-10,060
-0.9% -$925K 5.8% 6
2025
Q2
$103M Sell
1,181,002
-176
-0% -$14.9K 5.51% 7
2025
Q1
$106M Buy
1,181,178
+50,920
+5% +$4.56M 5.6% 6
2024
Q4
$90.3M Sell
1,130,258
-225,787
-17% -$19.5M 4.55% 8
2024
Q3
$122M Sell
1,356,045
-34,855
-3% -$2.93M 5.35% 8
2024
Q2
$109M Buy
1,390,900
+22,981
+2% +$1.88M 4.98% 8
2024
Q1
$119M Buy
1,367,919
+107,345
+9% +$9.16M 5.42% 7
2023
Q4
$104M Sell
1,260,574
-37,814
-3% -$2.88M 4.79% 7
2023
Q3
$102M Buy
1,298,388
+120,053
+10% +$10M 4.97% 7
2023
Q2
$104M Buy
1,178,335
+42,532
+4% +$3.66M 4.78% 7
2023
Q1
$91.6M Buy
1,135,803
+145,080
+15% +$11.8M 4.35% 9
2022
Q4
$77M Sell
990,723
-33,341
-3% -$2.7M 3.81% 10
2022
Q3
$82.7M Buy
1,024,064
+148,777
+17% +$13.4M 4.37% 7
2022
Q2
$78.6M Buy
875,287
+114,469
+15% +$11.6M 3.89% 9
2022
Q1
$84.4M Buy
760,818
+215,306
+39% +$22.7M 3.67% 12
2021
Q4
$56.4M Buy
545,512
+5,587
+1% +$647K 2.4% 22
2021
Q3
$67.7M Sell
539,925
-1,546
-0.3% -$200K 3.12% 15
2021
Q2
$67.2M Sell
541,471
-1,596
-0.3% -$200K 3.17% 15
2021
Q1
$64.2M Buy
543,067
+244
+0% +$28.6K 3.24% 14
2020
Q4
$63.6M Buy
542,823
+10,159
+2% +$1.12M 3.41% 12
2020
Q3
$55.4M Sell
532,664
-13,985
-3% -$1.4M 3.32% 13
2020
Q2
$50.1M Buy
546,649
+13,920
+3% +$1.33M 3.16% 15
2020
Q1
$48M Buy
532,729
+143,807
+37% +$15.3M 3.33% 13
2019
Q4
$44.1M Sell
388,922
-2,571
-0.7% -$282K 2.65% 17
2019
Q3
$42.5M Sell
391,493
-9,838
-2% -$1.03M 2.75% 16
2019
Q2
$39.1M Buy
401,331
+12,795
+3% +$1.17M 2.46% 17
2019
Q1
$35.4M Buy
388,536
+2,079
+0.5% +$186K 2.42% 18
2018
Q4
$35.2M Sell
386,457
-23,057
-6% -$2.15M 2.79% 17
2018
Q3
$40.3M Sell
409,514
-18,528
-4% -$1.71M 2.72% 16
2018
Q2
$36.6M Buy
428,042
+71,449
+20% +$5.97M 2.63% 16
2018
Q1
$28.6M Buy
356,593
+3,787
+1% +$312K 2.09% 22
2017
Q4
$28.5M Sell
352,806
-12,481
-3% -$1,000K 1.99% 24
2017
Q3
$28.4M Sell
365,287
-17,567
-5% -$1.46M 2.17% 22
2017
Q2
$34M Sell
382,854
-7,616
-2% -$642K 2.7% 18
2017
Q1
$31.5M Sell
390,470
-22,741
-6% -$1.78M 2.61% 20
2016
Q4
$29.4M Sell
413,211
-35,622
-8% -$2.8M 2.66% 22
2016
Q3
$38.8M Sell
448,833
-21,833
-5% -$1.9M 3.32% 13
2016
Q2
$40.8M Sell
470,666
-13,500
-3% -$1.09M 3.66% 12
2016
Q1
$36.3M Sell
484,166
-20,525
-4% -$1.55M 3.2% 17
2015
Q4
$38.8M Sell
504,691
-23,448
-4% -$1.77M 3.76% 10
2015
Q3
$35.4M Sell
528,139
-90,440
-15% -$6.66M 3.55% 11
2015
Q2
$45.8M Sell
618,579
-33,571
-5% -$2.56M 4.36% 5
2015
Q1
$50.9M Sell
652,150
-31,524
-5% -$2.39M 4.74% 3
2014
Q4
$49.4M Sell
683,674
-36,875
-5% -$2.56M 4.57% 5
2014
Q3
$44.6M Sell
720,549
-41,631
-5% -$2.65M 4.41% 6
2014
Q2
$48.6M Buy
762,180
+3,872
+0.5% +$235K 4.84% 4
2014
Q1
$46.7M Buy
758,308
+17,105
+2% +$996K 4.76% 4
2013
Q4
$42.5M Buy
741,203
+19,575
+3% +$1.11M 4.53% 6
2013
Q3
$38.4M Sell
721,628
-20,979
-3% -$1.13M 4.52% 5
2013
Q2
$38.2M Buy
+742,607
New +$36.7M 4.5% 5

Other funds holding MDT

Saratoga Research & Investment Management's MDT Position: Q2 2026 in Review

Saratoga Research & Investment Management increased its Medtronic (MDT) stake by 2.4% in Q2 2026, buying an estimated $2.24M and bringing the position to 1,203,285 shares worth $94.1M. The position accounts for 5.15% of the portfolio, ranked #8.

Saratoga Research & Investment Management first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $122M in Q3 2024. 1,402 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Saratoga Research & Investment Management held 1,203,285 shares of Medtronic worth $94.1M as of Q2 2026.
  • Saratoga Research & Investment Management bought 27,714 Medtronic shares in Q2 2026, an estimated $2.24M.
  • Medtronic made up 5.15% of Saratoga Research & Investment Management's portfolio in Q2 2026, its #8 holding.
  • Saratoga Research & Investment Management first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Saratoga Research & Investment Management's Medtronic position peaked at $122M in Q3 2024.
  • 1,402 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Saratoga Research & Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.